Literature DB >> 12522005

Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription.

Sansana Sawasdikosol1, Kristin M Russo, Steven J Burakoff.   

Abstract

Prostaglandin E(2) (PGE(2)) is the predominant eicosanoid product released by macrophages at the site of inflammation. Binding of PGE(2) to its cognate 7 transmembrane-spanning G protein-coupled receptors (GPCRs) activates signaling pathways, leading to the synthesis of the Fos transcription factor. Because the Ste20 serine/threonine protein kinase (S/TPK) is a critical signal transducer for the G protein-coupled pheromone receptor in Saccharomyces cerevisiae, we postulated that the PGE(2) GPCRs may activate one of the Ste20 mammalian orthologs. We demonstrate here that the catalytic activity of a hematopoietic cell-restricted, Ste20-related S/TPK, HPK1, is positively regulated by exposure to physiological concentrations of PGE(2). Furthermore, ectopic expression studies implicated HPK1 as a negative regulator of PGE(2)-induced transcription of the fos gene. Our data suggest that PGE(2)-induced activation of HPK1 may represent a novel negative regulatory pathway capable of modulating PGE(2)-mediated gene transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522005     DOI: 10.1182/blood-2002-07-2316

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  HPK1 as a novel target for cancer immunotherapy.

Authors:  Sansana Sawasdikosol; Renyuan Zha; Boyu Yang; Steven Burakoff
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 2.  Ste20-related proline/alanine-rich kinase: a novel regulator of intestinal inflammation.

Authors:  Yutao Yan; Didier Merlin
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

3.  Identification of Potent Reverse Indazole Inhibitors for HPK1.

Authors:  Elsie C Yu; Joey L Methot; Xavier Fradera; Charles A Lesburg; Brian M Lacey; Phieng Siliphaivanh; Ping Liu; Dustin M Smith; Zangwei Xu; Jennifer A Piesvaux; Shuhei Kawamura; Haiyan Xu; J Richard Miller; Mark Bittinger; Alexander Pasternak
Journal:  ACS Med Chem Lett       Date:  2021-03-01       Impact factor: 4.345

4.  Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance.

Authors:  Jinqi Liu; Joshua Curtin; Dan You; Stephen Hillerman; Bifang Li-Wang; Rukiye Eraslan; Jenny Xie; Jesse Swanson; Ching-Ping Ho; Simone Oppenheimer; Bethanne M Warrack; Colleen A McNaney; David M Nelson; Jordan Blum; Taeg Kim; Mark Fereshteh; Michael Reily; Petia Shipkova; Anwar Murtaza; Miguel Sanjuan; John T Hunt; Luisa Salter-Cid
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

5.  Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response.

Authors:  Saba Alzabin; Saiju Pyarajan; Herman Yee; Friedemann Kiefer; Akira Suzuki; Steven Burakoff; Sansana Sawasdikosol
Journal:  Cancer Immunol Immunother       Date:  2009-09-29       Impact factor: 6.968

Review 6.  A perspective on HPK1 as a novel immuno-oncology drug target.

Authors:  Sansana Sawasdikosol; Steven Burakoff
Journal:  Elife       Date:  2020-09-08       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.